Search research articles
Contact Us
Filters
Showing results (581-590 of 615) with videos related to
Page
of 62
Sort By:
BMC Cancer
|
February 18, 2025
Correction: Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression
Tingting Xu, Jianmin Huang, Jiajing Lin, et al.
Neuroscience Bulletin
|
December 13, 2019
Expression Patterns of Inducible Cre Recombinase Driven by Differential Astrocyte-Specific Promoters in Transgenic Mouse Lines
Neng-Yuan Hu, Ya-Ting Chen, Qian Wang, et al.
Cancer Medicine
|
January 10, 2018
Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients?
Wei Zhuang, Jing-Dun Xie, Shan Zhou, et al.
Neural Regeneration Research
|
July 23, 2015
Curcumin improves synaptic plasticity impairment induced by HIV-1gp120 V3 loop
Ling-Ling Shen, Ming-Liang Jiang, Si-Si Liu, et al.
Journal for Immunotherapy of Cancer
|
January 22, 2024
CD8<sup>+</sup> chimeric antigen receptor T cells manufactured in absence of CD4<sup>+</sup> cells exhibit hypofunctional phenotype
Sang Yun Lee, Dong Hoon Lee, Wei Sun, et al.
Journal of Gastroenterology
|
July 29, 2025
The pivotal role of SFRP2 in promoting glycolysis and progression in the high-risk group based on the glycometabolism prognostic model for colorectal cancer
Feng Du, Xu Ji, Jiayi Su, et al.
Cancer Medicine
|
March 31, 2023
Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications
Zhiming Zhao, Xiaomo Li, Fei Wang, et al.
Ecotoxicology and Environmental Safety
|
January 5, 2021
A case-control study on the association of mineral elements exposure and thyroid tumor and goiter
Mei Liu, Jiayi Song, Yousheng Jiang, et al.
Biomaterials
|
February 18, 2018
A multifaceted coating on titanium dictates osteoimmunomodulation and osteo/angio-genesis towards ameliorative osseointegration
Long Bai, Zhibin Du, Jingjing Du, et al.
Cancer Research
|
February 16, 2021
MEK Inhibition Remodels the Immune Landscape of Mutant <i>KRAS</i> Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors
Bin Yang, Xi Li, Yu Fu, et al.
Page
of 62
Search research articles
Search
Showing results (581-590 of 615) with videos related to
Sort By:
Page
of 62
BMC Cancer
|
February 18, 2025
Correction: Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression
Tingting Xu, Jianmin Huang, Jiajing Lin, et al.
Neuroscience Bulletin
|
December 13, 2019
Expression Patterns of Inducible Cre Recombinase Driven by Differential Astrocyte-Specific Promoters in Transgenic Mouse Lines
Neng-Yuan Hu, Ya-Ting Chen, Qian Wang, et al.
Cancer Medicine
|
January 10, 2018
Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients?
Wei Zhuang, Jing-Dun Xie, Shan Zhou, et al.
Neural Regeneration Research
|
July 23, 2015
Curcumin improves synaptic plasticity impairment induced by HIV-1gp120 V3 loop
Ling-Ling Shen, Ming-Liang Jiang, Si-Si Liu, et al.
Journal for Immunotherapy of Cancer
|
January 22, 2024
CD8<sup>+</sup> chimeric antigen receptor T cells manufactured in absence of CD4<sup>+</sup> cells exhibit hypofunctional phenotype
Sang Yun Lee, Dong Hoon Lee, Wei Sun, et al.
Journal of Gastroenterology
|
July 29, 2025
The pivotal role of SFRP2 in promoting glycolysis and progression in the high-risk group based on the glycometabolism prognostic model for colorectal cancer
Feng Du, Xu Ji, Jiayi Su, et al.
Cancer Medicine
|
March 31, 2023
Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications
Zhiming Zhao, Xiaomo Li, Fei Wang, et al.
Ecotoxicology and Environmental Safety
|
January 5, 2021
A case-control study on the association of mineral elements exposure and thyroid tumor and goiter
Mei Liu, Jiayi Song, Yousheng Jiang, et al.
Biomaterials
|
February 18, 2018
A multifaceted coating on titanium dictates osteoimmunomodulation and osteo/angio-genesis towards ameliorative osseointegration
Long Bai, Zhibin Du, Jingjing Du, et al.
Cancer Research
|
February 16, 2021
MEK Inhibition Remodels the Immune Landscape of Mutant <i>KRAS</i> Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors
Bin Yang, Xi Li, Yu Fu, et al.
Page
of 62